Corvus Pharmaceuticals (CRVS) Ownership - Who Owns Corvus Pharmaceuticals?

698 Followers

Corvus Pharmaceuticals (CRVS) Ownership Overview

22.33% Insiders

6.72% Mutual Funds

45.46% Other Institutional Investors

12.14% ETFs

13.35% Public Companies and

Individual Investors

The ownership structure of Corvus Pharmaceuticals (CRVS) stock is a mix of institutional, retail, and individual investors. Approximately 64.32% of the company’s stock is owned by Institutional Investors, 22.33% is owned by Insiders, and 13.35% is owned by Public Companies and Individual Investors.

The ownership structure of Corvus Pharmaceuticals (CRVS) stock is a mix of institutional, retail, and individual investors. Approximately 52.18% of the company’s stock is owned by Institutional Investors, 22.33% is owned by Insiders, and 12.14% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Perceptive Advisors Llc	xxxxxxxxxxxxx	$33538412
Mar 31, 2024	Ra Capital Management	xxxxxxxxxxxxx	$6583500
Mar 31, 2024	Towerview Llc	xxxxxxxxxxxxx	$1024100

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	8,819,091	Insider	10.49%	108,563,010
	7,165,006	Insider	8.52%	88,201,224
	3,879,817	Institution	4.61%	47,760,547
	3,050,143	Institution	3.63%	37,547,260
	2,696,615	Institution	3.21%	33,195,331
	2,433,568	Institution	2.89%	29,957,222
	2,324,810	Insider	2.76%	28,618,411
Joseph Edelman	2,292,441	Institution	2.73%	28,219,949
	723,585	Institution	0.86%	8,907,331
	607,550	Institution	0.72%	7,478,941

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
2,696,615	Institution	3.21%	33,195,331
723,585	Institution	0.86%	8,907,331
607,550	Institution	0.72%	7,478,941
340,809	Institution	0.41%	4,195,359
268,377	Institution	0.32%	3,303,721
179,324	Institution	0.21%	2,207,478
167,790	Institution	0.20%	2,065,495
99,801	Institution	0.12%	1,228,550
75,700	Institution	0.09%	931,867
70,546	Institution	0.08%	868,421

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	2,339,506	Institution	2.78%	34,226,973
SPDR S&P BIOTECH ETF	2,315,686	Institution	2.75%	36,610,996
iShares Russell 2000 ETF	1,506,158	Institution	1.79%	24,053,343
Vanguard Extended Market ETF	820,906	Institution	0.98%	12,009,855
iShares Russell 2000 Growth ETF	529,747	Institution	0.63%	8,460,060
iShares Biotechnology ETF	466,855	Institution	0.56%	7,455,674
Vanguard Russell 2000 ETF	316,859	Institution	0.38%	4,635,647
Vanguard Health Care ETF	167,119	Institution	0.20%	2,444,951
F/M Emerald Life Sciences Innovation ETF	165,305	Institution	0.20%	2,613,472
iShares Micro-Cap ETF	165,241	Institution	0.20%	2,638,899

FAQ

Who Owns Corvus Pharmaceuticals Inc (CRVS)?

According to the latest TipRanks data, approximately 45.46% of the company's stock is held by institutional investors, 22.33% is held by insiders, and 13.35% is held by retail investors.

What percentage of Corvus Pharmaceuticals Inc (CRVS) stock is held by institutional investors?

According to the latest TipRanks data, approximately 45.46% of Corvus Pharmaceuticals Inc (CRVS) stock is held by institutional investors.

What percentage of Corvus Pharmaceuticals Inc (CRVS) stock is held by retail investors?

According to the latest TipRanks data, approximately 13.35% of Corvus Pharmaceuticals Inc (CRVS) stock is held by retail investors.

Who owns the most shares of Corvus Pharmaceuticals Inc (CRVS)?

Peter A. Thompson owns the most shares of Corvus Pharmaceuticals Inc (CRVS).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.